Primus In News
Multinational pharma cos, Indian drugmakers diverge to mutual gain
11-03-2026
Vivek Tandon, Vice President, Primus Partners, shared that multinational corporations are experiencing financial pressure. "This change has less to do with financial strain and more to do with strategic alignment. Legacy brands may still generate cash, but they don’t fit an innovation-led, globally scalable model.
Explore Related Insights
- Can margin trading losses on equity investments be recovered from spouse’s demat account? SC rules yes, it can be in this case
- Bollywood’s investments in startups sees a sharp dip in 2024 at $3.6 million
- PhysicsWallah Shares To List Today: GMP Signals 13% Listing Pop; What Should Investors Expect?
- How Rajasthan is creating long-term income-generating opportunities for rural women
